NEXICLON XR Drug Patent Profile
✉ Email this page to a colleague
When do Nexiclon Xr patents expire, and what generic alternatives are available?
Nexiclon Xr is a drug marketed by Athena and is included in one NDA. There are two patents protecting this drug.
This drug has twenty-one patent family members in fourteen countries.
The generic ingredient in NEXICLON XR is clonidine. There are twenty-two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the clonidine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nexiclon Xr
A generic version of NEXICLON XR was approved as clonidine by AVEVA on August 18th, 2009.
Summary for NEXICLON XR
International Patents: | 21 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 69 |
Clinical Trials: | 4 |
Patent Applications: | 4,434 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in NEXICLON XR? | NEXICLON XR excipients list |
DailyMed Link: | NEXICLON XR at DailyMed |
Recent Clinical Trials for NEXICLON XR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Louisville | Phase 4 |
Arthroplasty Foundation, Inc. | Phase 4 |
Children's Hospital of Pittsburgh | N/A |
Pharmacology for NEXICLON XR
Drug Class | Central alpha-2 Adrenergic Agonist |
Mechanism of Action | Adrenergic alpha2-Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for NEXICLON XR
US Patents and Regulatory Information for NEXICLON XR
NEXICLON XR is protected by two US patents.
Patents protecting NEXICLON XR
Modified release formulations containing drug-ion exchange resin complexes
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Clonidine formulation
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Athena | NEXICLON XR | clonidine | TABLET, EXTENDED RELEASE;ORAL | 022500-001 | Dec 3, 2009 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Athena | NEXICLON XR | clonidine | TABLET, EXTENDED RELEASE;ORAL | 022500-002 | Dec 3, 2009 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Athena | NEXICLON XR | clonidine | TABLET, EXTENDED RELEASE;ORAL | 022500-001 | Dec 3, 2009 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for NEXICLON XR
See the table below for patents covering NEXICLON XR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Brazil | PI0709606 | formulações de liberação modificada contendo complexos fármaco-resina de troca iÈnica | ⤷ Try a Trial |
Spain | 2378573 | ⤷ Try a Trial | |
Austria | E536867 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |